[go: up one dir, main page]

ZA200810600B - Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists - Google Patents

Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Info

Publication number
ZA200810600B
ZA200810600B ZA200810600A ZA200810600A ZA200810600B ZA 200810600 B ZA200810600 B ZA 200810600B ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 B ZA200810600 B ZA 200810600B
Authority
ZA
South Africa
Prior art keywords
tumors
treatment
growth factor
receptor antagonists
factor receptor
Prior art date
Application number
ZA200810600A
Other languages
English (en)
Inventor
Rowinsky Eric
Original Assignee
Imclone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Systems Inc filed Critical Imclone Systems Inc
Publication of ZA200810600B publication Critical patent/ZA200810600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200810600A 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists ZA200810600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83348706P 2006-07-27 2006-07-27

Publications (1)

Publication Number Publication Date
ZA200810600B true ZA200810600B (en) 2009-11-25

Family

ID=38982334

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810600A ZA200810600B (en) 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Country Status (15)

Country Link
EP (1) EP2043688A4 (xx)
JP (1) JP2009544736A (xx)
KR (1) KR20090033841A (xx)
CN (1) CN101484186A (xx)
AU (1) AU2007279261A1 (xx)
BR (1) BRPI0712368A2 (xx)
CA (1) CA2654911A1 (xx)
CR (1) CR10486A (xx)
EA (1) EA200870603A1 (xx)
EC (1) ECSP089011A (xx)
MX (1) MX2008016187A (xx)
NO (1) NO20085182L (xx)
TN (1) TNSN08512A1 (xx)
WO (1) WO2008014386A2 (xx)
ZA (1) ZA200810600B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021019167A2 (pt) * 2019-03-27 2021-12-21 Nat Res Council Canada Anticorpos anti-egfrviii e fragmentos de ligação a antígeno dos mesmos

Also Published As

Publication number Publication date
CN101484186A (zh) 2009-07-15
ECSP089011A (es) 2009-01-30
TNSN08512A1 (en) 2010-04-14
JP2009544736A (ja) 2009-12-17
WO2008014386A3 (en) 2008-07-03
BRPI0712368A2 (pt) 2012-06-05
NO20085182L (no) 2009-04-24
CR10486A (es) 2009-02-23
AU2007279261A1 (en) 2008-01-31
WO2008014386A2 (en) 2008-01-31
EP2043688A4 (en) 2009-11-11
EP2043688A2 (en) 2009-04-08
MX2008016187A (es) 2009-01-20
EA200870603A1 (ru) 2009-06-30
CA2654911A1 (en) 2008-01-30
KR20090033841A (ko) 2009-04-06

Similar Documents

Publication Publication Date Title
IL281715A (en) Activin-ActrIIA antagonists and their use to increase bone growth in cancer patients
EP2131919A4 (en) IMPLANT BRAKING DEVICE FOR COMMUNICATING WITH BIOLOGICAL TISSUE
EP2426148A4 (en) ANTI-IL-3RA ANTIBODY FOR USE IN THE TREATMENT OF HEMATOMAS
PL2205185T3 (pl) Urządzenie do wytwarzania zakotwiczenia w tkance ludzkiej lub zwierzęcej
SI2282758T1 (sl) Protitelesa in vakcine za uporabo pri terapevtskih in diagnostičnih metodah za alfa-sinuklein-povezane motnje
BRPI1007877A2 (pt) "inibidores de dpp-iv para o tratamento de diabetes em pacientes pediátricos"
IL230911A0 (en) A system for the treatment of heart tissue and its use
IL213410A0 (en) Methods and compositions for diagnostic use in cancer patients
IL197157A0 (en) Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase
EP1991284A4 (en) BIOIMPLANTS FOR USE IN TISSUE GROWTH
IL205246A0 (en) Methods and compositions for diagnostic use in cancer patients
PL2227210T3 (pl) Łóżko pacjenta z urządzeniem nadzorującym i terapeutycznym
IL211953A0 (en) Implantable device for the delivery of octreotide and methods of use thereof
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
PT2320900T (pt) Utilização de opioides ou miméticos de opioides para o tratamento de pacientes com cancros resistentes
EP2271267A4 (en) MEDICAL DEVICE FOR THE PERI-OPERATIVE DELIVERY OF LIQUIDS AND METHOD FOR THE APPLICATION THEREOF
GB2475180B (en) Illumination apparatus for use in examining a body of living tissues
GB2460178B (en) Depsipeptides and their therapeutic use
GB2463474B (en) Therapeutic bone growth and regeneration
GB0908875D0 (en) Depsipeptides and their therapeutic use
ZA200810600B (en) Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists
EP2124950A4 (en) PAIN TREATMENT WITH NALOXONE
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
GB0809329D0 (en) Depsipeptides and their therapeutic use
GB0809326D0 (en) Depsipeptides and their therapeutic use